arginine and Non-alcoholic Fatty Liver Disease

arginine has been researched along with Non-alcoholic Fatty Liver Disease in 17 studies

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's11 (64.71)24.3611
2020's6 (35.29)2.80

Authors

AuthorsStudies
Baumann, A; Bergheim, I; Brandt, A; Jung, F; Nier, A; Rajcic, D; Sánchez, V; Staltner, R; Staufer, K; Trauner, M1
Bonnitcha, P; Fitzpatrick, M; Ireland, A; Koay, YC; Nguyen, VL; O'Sullivan, J; Sullivan, D1
Hu, Q; Hua, C; Huo, G; Jiang, H; Li, S; Wu, Y; Zhou, F; Zhu, H1
Gopko, OF; Lymanets, TV; Maslova, GS; Skrypnyk, IМ; Skrypnyk, RІ1
Bruno, RS; Cichon, MJ; Kopec, RE; Li, J; Sasaki, GY1
Baum, SJ; Chakravarthy, MV; Chera, H; Gunn, NT; Harrison, SA; Kohli, A; Koziel, MJ; Patil, R; Younes, ZH; Zhao, J1
Bergheim, I; De Bandt, JP; Degen, C; Engstler, AJ; Hasan Alkhatib, D; Jin, CJ; Nier, A; Sellmann, C1
Anavi, S; Hahn-Obercyger, M; Tirosh, O; Voloshin, I1
Bergheim, I; Beutheu, S; Cynober, L; De-Bandt, JP; Jegatheesan, P; Kapel, N; Nubret, E; Sarfati, G; Ventura, G; Waligora-Dupriet, AJ1
Dhakal, IB; Hakkak, R; Korourian, S; Zeng, H1
Alkim, C; Alkim, H; Bayram, M; Boga, S; Ergun, M; Koksal, AR; Neijmann, ST; Ozgon, G; Ozguven, MB1
Bergheim, I; Beutheu, S; De Bandt, JP; Jegatheesan, P; Nubret, E; Sarfati, G; Ventura, G1
Abu-Serie, MM; El-Gamal, BA; El-Kersh, MA; El-Saadani, MA1
Aslan, F; Bagci, S; Dogru, T; Ercin, CN; Genc, H; Kara, M; Kurt, I; Ors, F; Sertoglu, E; Sonmez, A; Tapan, S1
Colak, Y; Coskunpinar, E; Doganay, L; Kahraman, OT; Mesci, B; Ozturk, O; Senates, E; Tuncer, I; Ulasoglu, C; Yesil, A; Yilmaz, Y1
Aslan, F; Bagci, S; Dogru, T; Ercin, CN; Genc, H; Kara, M; Karslioglu, Y; Kurt, I; Ors, F; Sertoglu, E; Sonmez, A; Tapan, S1
Chayama, K; Fukami, K; Hyogo, H; Ishitobi, T; Kimura, Y; Maeda, S; Nakahara, T; Okuda, S; Ueda, S; Yamagishi, S1

Trials

1 trial(s) available for arginine and Non-alcoholic Fatty Liver Disease

ArticleYear
Safety, Tolerability, and Biologic Activity of AXA1125 and AXA1957 in Subjects With Nonalcoholic Fatty Liver Disease.
    The American journal of gastroenterology, 2021, 12-01, Volume: 116, Issue:12

    Topics: Acetylcysteine; Administration, Oral; Arginine; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Combinations; Drug Tolerance; Female; Glutamine; Humans; Isoleucine; Leucine; Liver; Magnetic Resonance Imaging; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Single-Blind Method; Treatment Outcome; Valine

2021

Other Studies

16 other study(ies) available for arginine and Non-alcoholic Fatty Liver Disease

ArticleYear
Alterations of nitric oxide homeostasis as trigger of intestinal barrier dysfunction in non-alcoholic fatty liver disease.
    Journal of cellular and molecular medicine, 2022, Volume: 26, Issue:4

    Topics: Animals; Arginine; Female; Homeostasis; Humans; Liver; Mice; Mice, Inbred C57BL; Nitric Oxide; Non-alcoholic Fatty Liver Disease; Toll-Like Receptor 4

2022
Design and validation of an LC-MS/MS method for simultaneous quantification of asymmetric dimethylguanidino valeric acid, asymmetric dimethylarginine and symmetric dimethylarginine in human plasma.
    Pathology, 2022, Volume: 54, Issue:5

    Topics: Arginine; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Female; Humans; Male; Non-alcoholic Fatty Liver Disease; Tandem Mass Spectrometry

2022
    Nutrients, 2022, Oct-01, Volume: 14, Issue:19

    Topics: Agaricales; Animals; Antioxidants; Arginine; Biomarkers; Diet, High-Fat; Fucose; Galactose; Glucose; Glycerides; Glycerol; Isoleucine; Leucine; Lipid Metabolism; Lipid Metabolism Disorders; Liver; Mannose; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Phospholipids; Polysaccharides; Proline; Spectroscopy, Fourier Transform Infrared; Steroids; Valine; Xylose

2022
Arginine/citrulline cycle changes in diet-induced rat model of non-alcoholic fatty liver disease.
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 2020, Volume: 73, Issue:6

    Topics: Animals; Arginine; Citrulline; Diet; Female; Liver; Male; Non-alcoholic Fatty Liver Disease; Rats; Rats, Sprague-Dawley

2020
Catechin-Rich Green Tea Extract and the Loss-of-TLR4 Signaling Differentially Alter the Hepatic Metabolome in Mice with Nonalcoholic Steatohepatitis.
    Molecular nutrition & food research, 2021, Volume: 65, Issue:2

    Topics: Acetyl Coenzyme A; Animals; Arginine; Bile Acids and Salts; Catechin; Dietary Supplements; Genotype; Glutathione; Insulin Resistance; Liver; Male; Metabolome; Mice, Inbred C3H; Mice, Mutant Strains; Non-alcoholic Fatty Liver Disease; Spermidine; Tea; Toll-Like Receptor 4

2021
Oral arginine supplementation protects female mice from the onset of non-alcoholic steatohepatitis.
    Amino acids, 2017, Volume: 49, Issue:7

    Topics: Administration, Oral; Animals; Arginine; Blood Glucose; Dietary Supplements; Female; Intestine, Small; Liver; Mice; Non-alcoholic Fatty Liver Disease; Tight Junctions; Toll-Like Receptor 4

2017
L-arginine conjugates of bile acids-a possible treatment for non-alcoholic fatty liver disease.
    Lipids in health and disease, 2014, Apr-22, Volume: 13

    Topics: Animals; Arginine; Body Weight; Chenodeoxycholic Acid; Eating; Esters; Liver; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease

2014
Effect of specific amino acids on hepatic lipid metabolism in fructose-induced non-alcoholic fatty liver disease.
    Clinical nutrition (Edinburgh, Scotland), 2016, Volume: 35, Issue:1

    Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Arginine; Aspartate Aminotransferases; Bilirubin; Blood Glucose; Cholesterol; Citrulline; Dietary Supplements; Fructose; Glutamine; Hypertriglyceridemia; Insulin; Insulin Resistance; Intestinal Absorption; Lipid Metabolism; Liver; Non-alcoholic Fatty Liver Disease; Rats; Rats, Sprague-Dawley; RNA, Messenger; Toll-Like Receptor 4; Triglycerides; Tumor Necrosis Factor-alpha

2016
Short- and Long-Term Soy Diet Versus Casein Protects Liver Steatosis Independent of the Arginine Content.
    Journal of medicinal food, 2015, Volume: 18, Issue:11

    Topics: Alanine Transaminase; Animals; Arginine; Aspartate Aminotransferases; Caseins; Diet; Dietary Supplements; Interleukin-6; Isoflavones; Liver; Male; Non-alcoholic Fatty Liver Disease; Obesity; Rats, Zucker; Soybean Proteins; Tumor Necrosis Factor-alpha

2015
Increased Plasma Levels of Asymmetric Dimethylarginine in Nonalcoholic Fatty Liver Disease: Relation With Insulin Resistance, Inflammation, and Liver Histology.
    Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2015, Volume: 63, Issue:7

    Topics: Adult; Arginine; C-Reactive Protein; Case-Control Studies; Female; Humans; Inflammation; Insulin Resistance; Liver; Male; Middle Aged; Non-alcoholic Fatty Liver Disease

2015
Citrulline and Nonessential Amino Acids Prevent Fructose-Induced Nonalcoholic Fatty Liver Disease in Rats.
    The Journal of nutrition, 2015, Volume: 145, Issue:10

    Topics: Algorithms; Amino Acids; Animals; Arginine; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Biomarkers; Citrulline; Dietary Supplements; Fatty Acid Synthase, Type I; Fructose; Gene Expression Regulation; Gene Expression Regulation, Enzymologic; Humans; Insulin Resistance; Liver; Male; Non-alcoholic Fatty Liver Disease; Ornithine; PPAR alpha; Random Allocation; Rats, Sprague-Dawley; Sterol Regulatory Element Binding Protein 1

2015
Investigation into the antioxidant role of arginine in the treatment and the protection for intralipid-induced non-alcoholic steatohepatitis.
    Lipids in health and disease, 2015, Oct-14, Volume: 14

    Topics: Animals; Antioxidants; Arginine; Cytochrome P-450 CYP2E1; Emulsions; Glutathione; Glutathione Peroxidase; Injections, Intraperitoneal; Injections, Intravenous; Lipid Peroxidation; Liver; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Non-alcoholic Fatty Liver Disease; Phospholipids; Protective Agents; Rats; Rats, Sprague-Dawley; Soybean Oil; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Tumor Necrosis Factor-alpha

2015
Elevated asymmetric dimethylarginine in plasma: an early marker for endothelial dysfunction in non-alcoholic fatty liver disease?
    Diabetes research and clinical practice, 2012, Volume: 96, Issue:1

    Topics: Adult; Arginine; Biomarkers; Carotid Artery Diseases; Carotid Intima-Media Thickness; Fatty Liver; Humans; Male; Non-alcoholic Fatty Liver Disease; Young Adult

2012
Assessment of endothelial function in patients with nonalcoholic fatty liver disease.
    Endocrine, 2013, Volume: 43, Issue:1

    Topics: Adult; Arginine; Atherosclerosis; Brachial Artery; Carotid Arteries; Carotid Intima-Media Thickness; Case-Control Studies; Early Diagnosis; Endothelium, Vascular; Fatty Liver; Female; Humans; Insulin Resistance; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Practice Guidelines as Topic; Predictive Value of Tests; Severity of Illness Index; Vascular Diseases; Vasodilation

2013
Plasma fetuin-A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver disease.
    Clinical endocrinology, 2013, Volume: 78, Issue:5

    Topics: Adiponectin; Adult; alpha-2-HS-Glycoprotein; Arginine; Atherosclerosis; Carotid Artery Diseases; Carotid Intima-Media Thickness; Fatty Liver; Female; Humans; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Young Adult

2013
Serum asymmetric dimethylarginine levels are independently associated with procollagen III N-terminal peptide in nonalcoholic fatty liver disease patients.
    Clinical and experimental medicine, 2014, Volume: 14, Issue:1

    Topics: Adult; Aged; Arginine; Fatty Liver; Female; Humans; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Peptide Fragments; Procollagen; Serum

2014